Stocktoria
Dogwood Therapeutics, Inc. DWTX
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2020-12-17
Dogwood Therapeutics, Inc. statistics & valuation
Market cap$55.5M
P / B0.7×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | -38.0% | -13.1% | -127.1% | -146.3% | -101.2% |
| Return on equity | -45.7% | 122.0% | -139.1% | -167.2% | -110.1% |
| Current ratio | 2.76 | 5.21 | 11.62 | 8.02 | 12.37 |
Source: SEC EDGAR filings · CIK 0001818844 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.